how were glp 1 agonists discovered Reflections on the discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions A Closer Look at the
Description
GLP-1 agonists are not exactly new, although this is a common misconception

While extensive data reassure their use, more trials are needed, particularly for populations like children, older adults, and those with severe illness

Storage conditions between injections matter as well

If a patient were to just take the medication without any kind of lifestyle or behavior change, they could expect to lose between 15% and 20% of their body weight, depending on the specific GLP-1 they're taking

In addition, we recorded dosages of the GLP-1-RA and of IIH medication, adherence to the GLP-1-RA treatment and adverse events (AEs) at M3 and M6

Back Vinfuture Prize Laureates, 'Professor Joel Francis Habener'
